comparemela.com

Latest Breaking News On - Kumar raja - Page 6 : comparemela.com

Acrturus Therapeutics Holdings Inc (ARCT) CEO Joseph Payne on Q2 2022 Results - Earnings Call Transcript

Acrturus Therapeutics Holdings Inc. Q2 2022 Earnings Conference Call August 09, 2022 04:30 PM ET Company Participants Joseph Payne - President and Chief Executive Officer Andrew Sassine -.

United statesUnited kingdomRepublic ofHan iKumar rajaYale jenRaymond jamesSeamus fernandezPiper sandlerAndy sassineJoseph payneSteve seedhouseAndrew sassineSteven seedhouseYasmeen rahimiKumaraguru raja

Oncternal Therapeutics, Inc (ONCT) Q2 2022 Earnings Call Transcript

ONCT earnings call for the period ending June 30, 2022.

United statesSan diegoDana farber cancer instituteKumar rajaCarl byrnesJames breitmeyerHartaj singhMiltenyi biotecHartaj singh oppenheimerRobert burnsJim breitmeyerKumar raja brooklineSalim yazjiCarl byrnes northlandCalifornia institute for regenerative medicineKarolinska institute

Caladrius Biosciences, Inc (CLBS) CEO David Mazzo on Q2 2022 Results - Earnings Call Transcript

Caladrius Biosciences, Inc. (NASDAQ:NASDAQ:CLBS) Q2 2022 Results Conference Call August 04, 2022 4:30 PM ET Company Participants John Menditto - VP, IR & Corporate Communications David.

United statesNew zealandNew south walesKumar rajaDavid mazzoJohn mendittoPete enderlinJames niscoCaladrius biosciencesCompany participantsCaladrius biosciences incNational healthCorporate communications at caladriusIr corporate communicationsUniversity of sydneyExchange commission

Medicenna Therapeutics Corp (MDNA) CEO Fahar Merchant on Q4 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (NASDAQ:NASDAQ:MDNA) Q4 2022 Earnings Conference Call June 22, 2022 8:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Fahar Merchant - President.

United statesKumar rajaMatt bieglerDavid martinLiz williamsSwayampakula ramakanthMartin bexonShubhendu royDavid bautzAndre uddinCatherine novackCompany participantsCap researchDevelopment advisory committeeMackie research capitalMedicenna therapeutics corp

Celsion Corporation (CLSN) CEO Michael Tardugno on Q1 2022 Results - Earnings Call Transcript

Celsion Corporation (NASDAQ:NASDAQ:CLSN) Q1 2022 Earnings Conference Call May 16, 2022 11:00 ET Company Participants Monique Kosse - Investor Relations Michael Tardugno - Chairman, Chief.

United statesNew jerseyState of new jerseyKumar rajaMichael tardugnoJeff churchEmily bodnarMonique kosseNicholas borysDavid bautzNick borysCompany participantsCelsion corporationCap researchGynecologic oncology groupWorld vaccine congress

vimarsana © 2020. All Rights Reserved.